Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTP-binding protein REM 1 (REM1) is a member of the RGK (Rad, Gem, Rem, Rem2) family of small GTPases. It acts as a regulator of voltage-dependent calcium channels, inhibiting their activity and therefore influencing cellular calcium influx. REM1 is primarily implicated in cardiovascular tissue, where it helps regulate electrical activity and contractility in the heart. Unlike RRAD, clinical or translational links to disease are limited for REM1, but its paralogs such as RRAD are associated with cardiac and metabolic disorders.
Not applicable (no drugs known); general mechanism: inhibition of voltage-dependent calcium channels affecting cellular excitability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTP-binding protein REM 1 (REM1).